Vitamin D3 Alone Is Incomplete (The Two Nutrients You Need With It)
Vitamin D3 is sold as a single supplement, taken alone, and most people assume that's enough. The dose goes up, the blood level goes up, and the job is done. That's the model most people are working from, and it's missing two steps that change whether any of this actually works.
Start with what D3 actually is when you swallow it.
The pill you take is biologically inactive. Your body cannot use it in that form. It has to go through two separate conversion steps before it does anything, and the first happens in your liver, and the second happens in your kidneys, and both of those steps are run by enzymes that depend on magnesium to function. The liver enzyme is called CYP2R1, which converts D3 into something called 25-hydroxyvitamin D, and the kidney enzyme is called CYP27B1, which converts that intermediate form into the final active version your cells can actually read. Magnesium is not optional in either step. It is the cofactor that makes those enzymes run.
So if your magnesium is low, those enzymes slow down, and the D3 you swallowed sits in your bloodstream in a form your body cannot use.
About half of Americans are not getting enough magnesium from food, based on national intake data, and this matters because low magnesium is not dramatic. You do not feel it as a deficiency the way you feel low iron. It just quietly limits dozens of enzymatic processes, including the two required to activate D3.
A randomized trial published in the American Journal of Clinical Nutrition in 2018 put this directly to the test. They gave people magnesium alongside D3 and found that it raised 25-hydroxyvitamin D levels in people who were starting from a deficient baseline, and it also reduced levels in people who were already high. The same intervention moved deficient people up and high people down, which tells you something important: magnesium was allowing the body to regulate the conversion process, not just accelerate it in one direction. Without sufficient magnesium, that regulatory system stalls.
That is the first problem. But there is a second one that begins exactly where the first one ends.
Once D3 is fully activated, it increases how much calcium your gut absorbs from food. This is what D3 is supposed to do. Calcium absorption is one of its primary functions and the reason it matters for bone density. But here is what the model leaves out: increasing calcium absorption and getting that calcium into bone are two different things. The calcium gets absorbed either way. Where it goes next is a separate question.
Think of it like filling a tank. D3 opens the valve and lets more calcium in. But without something directing the flow, that calcium ends up wherever pressure takes it, and in the body, that can mean soft tissue and arterial walls instead of bone.
What controls where the calcium goes is vitamin K2, which activates two proteins that do specific jobs. The first is called osteocalcin, which pulls calcium into bone. The second is called Matrix Gla Protein, which suppresses calcium from depositing in arterial walls. Both of these proteins exist in your body already, but they are inactive in their default state. K2 is what switches them on.
This is not theoretical. A study from Rotterdam followed 4,807 people for seven years and looked at how dietary vitamin K2 intake related to heart disease outcomes. People in the highest third of K2 intake had a 57 percent lower risk of dying from coronary heart disease compared to people in the lowest third. That association held after adjusting for other variables.
A separate clinical trial looked at what MK-7, which is the specific form of K2 with the longest half-life in the body, does to arterial stiffness directly. They gave 180 micrograms per day of MK-7 to healthy postmenopausal women for three years and measured arterial stiffness at the end. The MK-7 group had significantly better arterial stiffness scores than the placebo group. The mechanism behind that finding is Matrix Gla Protein doing the job K2 allows it to do.
So the picture looks like this. D3 needs magnesium to become active, and then once active it increases calcium absorption, and then K2 is what tells that calcium to go to bone instead of accumulating in places it should not be. Remove any step and the chain breaks.
On the practical side, the dose range that shows up in the research is 4,000 to 5,000 IU of D3 per day, 200 to 400 milligrams of magnesium in a form like magnesium glycinate which absorbs well and is less likely to cause digestive issues, and 100 to 200 micrograms of K2 as MK-7. Both D3 and K2 are fat-soluble, which means they absorb better when taken with a meal that has some fat in it. Taking them on an empty stomach reduces how much you actually absorb.
The form of K2 matters here. MK-4 and MK-7 are both forms of K2, but MK-7 has a much longer half-life in the body, meaning it stays active between doses, which is why most research on K2 supplementation uses MK-7.
Most supplement conversations are about whether to take something. The more useful question is whether the system around it is complete, because D3 by itself is not the end of the chain. It is the beginning of one, and the rest of the chain needs to be there for it to work.
References
- Dai Q, Zhu X, Manson JE, et al. (2018). Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial. American Journal of Clinical Nutrition, 108(6):1249-1258. DOI: 10.1093/ajcn/nqy274. PMID: 30541089. Finding: Magnesium supplementation optimized 25(OH)D concentrations, increasing them in those with baseline deficiency and reducing them in those with high baseline levels.
- Rosanoff A, Weaver CM, Rude RK. (2012). Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutrition Reviews, 70(3):153-164. DOI: 10.1111/j.1753-4887.2011.00465.x. PMID: 22364157. Finding: Approximately 50% of Americans consume less than the Estimated Average Requirement for magnesium from food.
- Geleijnse JM, Vermeer C, Grobbee DE, et al. (2004). Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. Journal of Nutrition, 134(11):3100-3105. DOI: 10.1093/jn/134.11.3100. PMID: 15514282. Finding: Highest tertile of dietary vitamin K2 (menaquinone) intake associated with 57% lower risk of CHD mortality in 4,807 subjects followed for 7 years.
- Knapen MHJ, Braam LAJLM, Drummen NE, et al. (2015). Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thrombosis and Haemostasis, 113(5):1135-1144. DOI: 10.1160/TH14-08-0675. PMID: 25694037. Finding: 180 mcg/day MK-7 supplementation for 3 years significantly improved arterial stiffness (Stiffness Index beta) compared to placebo.
- Uwitonze AM, Razzaque MS. (2018). Role of magnesium in vitamin D activation and function. Journal of the American Osteopathic Association, 118(3):181-189. DOI: 10.7556/jaoa.2018.037. PMID: 29480918. Finding: Magnesium is required as a cofactor for both CYP2R1 (liver 25-hydroxylation) and CYP27B1 (kidney 1-alpha-hydroxylation) of vitamin D.
Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness
If this is the kind of information you want access to on a daily basis, the community is free and there are full courses on training, nutrition, hormones, and supplementation inside. You can ask questions and post your own labs and get feedback from me and from the community.